Repurposing bioactive compounds for treating multidrug-resistant pathogens.
Conclusion. Although these compounds' potential for repurposing is limited by their toxicity, our results contribute to this growing field and provide a simple road map for using C. elegans for preliminary testing of known bioactive compounds with predicted antimicrobial activity.
PMID: 32163353 [PubMed - as supplied by publisher]
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Hummell NA, Kirienko NV Tags: J Med Microbiol Source Type: research
More News: Antimicrobial Resistance | Eloxatin | Enterococcus | Insulin | Microbiology | Multidrug Resistance | Toxicology